Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review
Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world's first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.
Osiris Therapeutics Inc Key Recent Developments
Mar 13,2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world's first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.
Osiris Therapeutics Inc Key Recent Developments
Mar 13,2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Osiris Therapeutics Inc - Key Facts
Osiris Therapeutics Inc - Key Employees
Osiris Therapeutics Inc - Key Employee Biographies
Osiris Therapeutics Inc - Major Products and Services
Osiris Therapeutics Inc - History
Osiris Therapeutics Inc - Company Statement
Osiris Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Osiris Therapeutics Inc - Business Description
Osiris Therapeutics Inc - Corporate Strategy
Osiris Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Osiris Therapeutics Inc - Strengths
Osiris Therapeutics Inc - Weaknesses
Osiris Therapeutics Inc - Opportunities
Osiris Therapeutics Inc - Threats
Osiris Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 13, 2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Osiris Therapeutics Inc - Key Facts
Osiris Therapeutics Inc - Key Employees
Osiris Therapeutics Inc - Key Employee Biographies
Osiris Therapeutics Inc - Major Products and Services
Osiris Therapeutics Inc - History
Osiris Therapeutics Inc - Company Statement
Osiris Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Osiris Therapeutics Inc - Business Description
Osiris Therapeutics Inc - Corporate Strategy
Osiris Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Osiris Therapeutics Inc - Strengths
Osiris Therapeutics Inc - Weaknesses
Osiris Therapeutics Inc - Opportunities
Osiris Therapeutics Inc - Threats
Osiris Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 13, 2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Osiris Therapeutics Inc, Key Facts
Osiris Therapeutics Inc, Key Employees
Osiris Therapeutics Inc, Key Employee Biographies
Osiris Therapeutics Inc, Major Products and Services
Osiris Therapeutics Inc, History
Osiris Therapeutics Inc, Subsidiaries
Osiris Therapeutics Inc, Key Competitors
Osiris Therapeutics Inc, Ratios based on current share price
Osiris Therapeutics Inc, Annual Ratios
Osiris Therapeutics Inc, Annual Ratios (Cont...1)
Osiris Therapeutics Inc, Interim Ratios
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Osiris Therapeutics Inc, Key Facts
Osiris Therapeutics Inc, Key Employees
Osiris Therapeutics Inc, Key Employee Biographies
Osiris Therapeutics Inc, Major Products and Services
Osiris Therapeutics Inc, History
Osiris Therapeutics Inc, Subsidiaries
Osiris Therapeutics Inc, Key Competitors
Osiris Therapeutics Inc, Ratios based on current share price
Osiris Therapeutics Inc, Annual Ratios
Osiris Therapeutics Inc, Annual Ratios (Cont...1)
Osiris Therapeutics Inc, Interim Ratios
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Osiris Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Osiris Therapeutics Inc, Performance Chart (2014 - 2018)
Osiris Therapeutics Inc, Ratio Charts
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Geron Corp
CymaBay Therapeutics Inc
MiMedx Group Inc
Merakris Therapeutics LLC
Symic Bio Inc
Astellas Institute for Regenerative Medicine
Athersys Inc
Vericel Corp
Plus Therapeutics Inc
MultiCell Technologies Inc
Microbot Medical Inc
Cellerant Therapeutics Inc
Osiris Therapeutics Inc, Performance Chart (2014 - 2018)
Osiris Therapeutics Inc, Ratio Charts
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
COMPANIES MENTIONED
Geron Corp
CymaBay Therapeutics Inc
MiMedx Group Inc
Merakris Therapeutics LLC
Symic Bio Inc
Astellas Institute for Regenerative Medicine
Athersys Inc
Vericel Corp
Plus Therapeutics Inc
MultiCell Technologies Inc
Microbot Medical Inc
Cellerant Therapeutics Inc